European Partnership for Pandemic Preparedness (Phase 2)

P

Usamos cookies essenciais, analíticas e publicidade para melhorar a experiência, medir a utilização e otimizar campanhas.

Saiba mais em Política de Privacidade · Termos de Serviço · Política de Cookies

Description

Europe

Health & Life Sciences•70% • 33M€

Pending

Dates & Deadlines

Publication Date

Not defined

Opening Date

February 10, 2027

Application Phases

Fase única

April 13, 2027 at 05:00 PM

Financial Details

Non-Refundable

Maximum Funding Rate

70%

Budget

33M€

Eligible Project Value

Up to 33M€

Criteria & Documents

Eligible Expenses

●Personnel Costs
●Travel costs
●Equipment costs
●Other goods, works and services costs
●Subcontracting
●Indirect Costs
●Equipment
●Travel

Access Conditions

●Legal entities from EU Member States and Associated Countries
●Consortium must include partners from at least three different EU Member States or Associated Countries
●Compliance with general and specific admissibility and eligibility criteria

Selection Criteria

●Excellence (scientific and technical merit)
●Impact (contribution to policy and partnership KPIs)
●Quality and efficiency of implementation

Mandatory Information

●Application form (Part A and Part B)
●Budget

EU Programme Details

Call ID: HORIZON-HLTH-2026-03-DISEASE-13
Cluster: Health
Destination: D3. Tackling diseases and reducing disease burden
Submission Mode: Single-stage
EU Contribution: Around €33,000,000.00 per project
Expected Projects: 1 project
Funding Rate Rule: he funding rate is 50% of the eligible costs as co-fund actions require the remainder of the cost to be secured from other sources.

Funding Rate

70%

Budget

33M€

Curated by

Marlene Faria

Eligibility

Eligible Sectors

Health & Life Sciences

Company Typologies

MicroSMESmall Mid-CapMid-CapLargeNon-business entities of the R&I system (ENESII)Private non-profit entitiesPublic entities

Application Mode

Consortium / Copromotion

Official Links

Official Regulation